ESOPMay 18, 2026, 04:32 PM
Fennec Pharmaceuticals Grants 50,000 Stock Options to New Employees
AI Summary
Fennec Pharmaceuticals announced the grant of stock option awards for 50,000 common shares to three new non-executive employees. These options were approved by the Compensation Committee on May 11, 2026, with a grant date of May 18, 2026, under the 2026 Equity Inducement Plan. The exercise price is $9.75 per share, and the options vest over three years, starting one year from the grant date, subject to continued employment.
Key Highlights
- Fennec Pharmaceuticals granted 50,000 stock options to three new non-executive employees.
- Options were approved on May 11, 2026, with a grant date of May 18, 2026.
- The grant includes 49,141 incentive and 859 nonqualified stock options.
- Exercise price is $9.75 per share, based on March 15, 2026 closing price.
- Options have a 10-year term from the date of grant.
- Vesting begins one year from grant date, then monthly over 24 months.
Price Impact
More from FENC